In clinical trials, however, several of these irreversible EGFR-TKIs failed to meet their primary endpoints in EGFR-TKI-refractory lung cancer and induced severe toxicities, such as diarrhea, skin rash/acne, stomatitis, and nail effects [1,20]. Here, EGFR is linked to Skin rash.